Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE2, PHASE3
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Condition: Esophageal Squamous Cell Carcinoma
NCT07251062
A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal
Stopped reason
Context when available
No stop reason available in the current public record.